BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37247662)

  • 21. Proton Therapy for 166 Patients with Iris Melanoma: Side Effects and Oncologic Outcomes.
    Gollrad J; Böker A; Vitzthum S; Besserer A; Heufelder J; Gauger U; Böhmer D; Budach V; Zeitz O; Joussen AM
    Ophthalmol Retina; 2023 Mar; 7(3):266-274. PubMed ID: 36087876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Glaucoma treatment].
    Bluwol E
    Rev Prat; 2016 May; 66(5):508-513. PubMed ID: 30512573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclodestructive procedures for non-refractory glaucoma.
    Michelessi M; Bicket AK; Lindsley K
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD009313. PubMed ID: 29694684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravitreal bevacizumab as therapy for refractory neovascular glaucoma secondary to iris metastasis of breast carcinoma.
    Vale S; Montalvo L; Baez E; Oliver AL
    Am J Ophthalmol Case Rep; 2018 Mar; 9():45-47. PubMed ID: 29468218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Neovascular glaucoma--etipathogeny and diagnosis].
    Călugăru D; Călugăru M
    Oftalmologia; 2012; 56(2):3-14. PubMed ID: 23424756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iris metastasis from systemic cancer in 104 patients: the 2014 Jerry A. Shields Lecture.
    Shields CL; Kaliki S; Crabtree GS; Peshtani A; Morton S; Anand RA; Coco G; Shields JA
    Cornea; 2015 Jan; 34(1):42-8. PubMed ID: 25343701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective evaluation of micropulse transscleral diode cyclophotocoagulation in refractory glaucoma: 1 year results.
    Jammal AA; Costa DC; Vasconcellos JPC; Costa VP
    Arq Bras Oftalmol; 2019 Jun; 82(5):381-388. PubMed ID: 31271570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glaucoma as the presenting sign of intraocular tumors: beware of the masquerading sign.
    Vempuluru VS; Jakati S; Krishnamurthy R; Senthil S; Kaliki S
    Int Ophthalmol; 2020 Jul; 40(7):1789-1795. PubMed ID: 32198607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carcinoma metastatic to the eye and orbit II. A clinicopathological study of 26 patients with carcinoma metastatic to the anterior segment of the eye.
    Ferry AP; Font RL
    Arch Ophthalmol; 1975 Jul; 93(7):472-82. PubMed ID: 166633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Semiconductor diode laser transscleral cyclophotocoagulation in patients with glaucoma.
    Hennis HL; Stewart WC
    Am J Ophthalmol; 1992 Jan; 113(1):81-5. PubMed ID: 1728152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transscleral cyclophotocoagulation with MicroPulse
    Fili S; Kontopoulou K; Vastardis I; Perdikakis G; Papadonta SA; Armeni EZ; Kohlhaas M
    Int Ophthalmol; 2021 Apr; 41(4):1271-1282. PubMed ID: 33392944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visual loss after transscleral diode laser cyclophotocoagulation for primary open-angle and neovascular glaucoma.
    Pokroy R; Greenwald Y; Pollack A; Bukelman A; Zalish M
    Ophthalmic Surg Lasers Imaging; 2008; 39(1):22-9. PubMed ID: 18254347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravitreal bevacizumab in refractory neovascular glaucoma: a prospective, observational case series.
    Kotecha A; Spratt A; Ogunbowale L; dell'Omo R; Kulkarni A; Bunce C; Franks WA
    Arch Ophthalmol; 2011 Feb; 129(2):145-50. PubMed ID: 21320957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Secondary glaucoma due to progressive iris atrophy--a century after the first description. Case report].
    Jurowski P; Goś R; Kapica A; Zdzieszyńska M
    Klin Oczna; 2004; 106(1-2):80-2. PubMed ID: 15218772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Secondary glaucoma caused by iris tumor. Iris metastasis of adenocarcinoma of the breast].
    Höche A; Blum M; Semeniuk C; Lorenz P; Kosmehl H; Strobel J
    Ophthalmologe; 1999 May; 96(5):342-3. PubMed ID: 10414125
    [No Abstract]   [Full Text] [Related]  

  • 36. Intravitreal bevacizumab for iris metastasis of small-cell lung carcinoma with neovascular glaucoma.
    Nakashima C; Keino H; Watanabe T; Taki W; Okada AA
    Jpn J Ophthalmol; 2011 Jan; 55(1):80-1. PubMed ID: 21331703
    [No Abstract]   [Full Text] [Related]  

  • 37. [Intraocular pressure results of contact transscleral cyclophotocoagulation with Neodymium YAG laser for refractory glaucoma].
    Quintyn JC; Grenard N; Hellot MF; Gruber D; Brasseur G
    J Fr Ophtalmol; 2003 Oct; 26(8):808-12. PubMed ID: 14586221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uveitis-Glaucoma-Hyphaema Syndrome. General review.
    Zemba M; Camburu G
    Rom J Ophthalmol; 2017; 61(1):11-17. PubMed ID: 29450365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of neovascular glaucoma with transscleral cyclophotocoagulation with diode laser alone versus combination transscleral cyclophotocoagulation with diode laser and intravitreal bevacizumab.
    Fong AW; Lee GA; O'Rourke P; Thomas R
    Clin Exp Ophthalmol; 2011; 39(4):318-23. PubMed ID: 20973900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endoscopic cyclophotocoagulation for the treatment of glaucoma: an Asian experience.
    Yip LW; Yong SO; Earnest A; Ji J; Lim BA
    Clin Exp Ophthalmol; 2009 Sep; 37(7):692-7. PubMed ID: 19788666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.